Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 134, Issue 5
August 1 2019
Issue Cover

Table of Contents

BLOOD COMMENTARY

Red Cells, Iron, and Erythropoiesis
Epo receptor marks the spot
Robert F. Paulson
View Articletitled, Epo receptor marks the spot

BLOOD SPOTLIGHT

How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns
Clinical Trials & Observations
Marshall A. Mazepa,Camila Masias,Shruti Chaturvedi
View Articletitled, How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns

CLINICAL TRIALS AND OBSERVATIONS

Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
Clinical Trials & Observations
Ajai Chari,Joaquín Martinez-Lopez,María-Victoria Mateos,Joan Bladé,Lotfi Benboubker,Albert Oriol,Bertrand Arnulf,Paula Rodriguez-Otero,Luis Pineiro,Andrzej Jakubowiak,Carla de Boer,Jianping Wang,Pamela L. Clemens,Jon Ukropec,Jordan Schecter,Sagar Lonial,Philippe Moreau
View Articletitled, Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma

LYMPHOID NEOPLASIA

ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
Chi-Ling Chiang,Swagata Goswami,Frank W. Frissora,Zhiliang Xie,Pearlly S. Yan,Ralf Bundschuh,Logan A. Walker,Xiaomeng Huang,Rajeswaran Mani,Xiaokui M. Mo,Sivasubramanian Baskar,Christoph Rader,Mitch A. Phelps,Guido Marcucci,John C. Byrd,L. James Lee,Natarajan Muthusamy
View Articletitled, ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
Supplemental data
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Tabea C. Froehlich,Karin Müller-Decker,Jana D. Braun,Thomas Albrecht,Anne Schroeder,Karsten Gülow,Sergij Goerdt,Peter H. Krammer,Jan P. Nicolay
View Articletitled, Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Supplemental data

MYELOID NEOPLASIA

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
Javier I. Muñoz-González,Iván Álvarez-Twose,María Jara-Acevedo,Ana Henriques,Esther Viñas,Carlos Prieto,Laura Sánchez-Muñoz,Carolina Caldas,Andrea Mayado,Almudena Matito,Noelia Dasilva-Freire,Alberto Orfao,Andrés C. García-Montero
View Articletitled, Frequency and prognostic impact of <em>KIT</em> and other genetic variants in indolent systemic mastocytosis
Supplemental data
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua,Lasse Kjaer,Vibe Skov,Niels Pallisgaard,Hans C. Hasselbalch,Christina Ellervik
View Articletitled, Prevalence and phenotypes of <em>JAK2</em> V617F and <em>calreticulin</em> mutations in a Danish general population
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Identification and transcriptome analysis of erythroblastic island macrophages
Wei Li,Yaomei Wang,Huizhi Zhao,Huan Zhang,Yuanlin Xu,Shihui Wang,Xinhua Guo,Yumin Huang,Shijie Zhang,Yongshuai Han,Xianfang Wu,Charles M. Rice,Gang Huang,Patrick G. Gallagher,Avital Mendelson,Karina Yazdanbakhsh,Jing Liu,Lixiang Chen,Xiuli An
View Articletitled, Identification and transcriptome analysis of erythroblastic island macrophages
Supplemental data

BLOOD WORK

Giant intracytoplasmic inclusions in a T-cell large granular lymphocytic leukemia patient with acute severe anemia
Schnyder Coffy,Min Shi
View Articletitled, Giant intracytoplasmic inclusions in a T-cell large granular lymphocytic leukemia patient with acute severe anemia
All Issues

Advertisement

CD20-bispecific antibodies improve response to CD19-CAR T-cells in lymphoma in-vitro and CLL in-vivo models
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of cell cycle
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement